Cite
HARVARD Citation
Malloy, J. et al. (2018). Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double‐blind, placebo‐controlled clinical trial. Diabetes, obesity & metabolism. 20 (8), pp. 1878-1884. [Online].